What 'maintenance dose' actually means and why nobody explains it

A patient at a Bangkok clinic told me she'd just had her three-month follow-up. The doctor used the phrase "maintenance dose" three times in the consultation. He didn't define it. She nodded each time, the way patients do when they're worried about asking a question that might make them seem uninformed. Afterward she asked me what it meant.

The honest answer is that nobody knows for sure yet. The medication hasn't been around long enough at population scale for there to be a confident standard. What we're learning is informative, though, and worth talking about because the gap between what's known and what gets said in clinic visits is wide.

Here's what's actually happening when prescribers use the term.

The dose escalation schedule for tirzepatide on the label takes patients from 2.5mg through 5mg, 7.5mg, 10mg, and up to 12.5mg or 15mg over five to seven months. Each step is supposed to give the body time to adjust to the increased GLP-1 + GIP receptor activity. The clinical trials that got the drug approved tested specific doses for specific durations and reported the resulting weight loss. The trials weren't designed around the question of what dose people should be on three years later, after they've reached a weight that works for them.

In the absence of trial data, what's emerging is a practice pattern. Patients who reach a stable weight at 10mg often discover they can step down and hold that weight at 5mg or 7.5mg. Some can hold at 2.5mg. Some discover that stepping down causes the weight to start creeping back, which tells them they need the higher dose to maintain. The maintenance dose is whatever dose holds the weight you've reached without triggering regain or unbearable side effects.

This is a fundamentally individual question. Two patients with similar starting weights and similar journeys can need very different maintenance doses. Body composition matters. Activity level matters. Diet matters. The maintenance dose is collaborative and discovered, not prescribed off a chart.

What this means in practice for a patient at month nine or twelve who's plateaued at a weight they're happy with:

The conversation worth having with your prescriber is about stepping down deliberately. If you're at 10mg and weight is steady, ask about going to 7.5mg for two months and watching what happens. If weight stays stable, drop to 5mg. If it starts creeping back, hold or go back up. The point is to find the lowest dose that does the job, because lower dose typically means fewer residual side effects and lower cost.

What this should not mean: a permanent indefinite higher dose because that's what got you to your target. The dose that helped you lose isn't necessarily the dose you need to keep what you lost.

The other thing prescribers often mean by "maintenance dose" is the dose you'll be on forever. That framing is what makes patients anxious. Forever is a long time. The medication has been on the market long enough now (since 2022 in the US for diabetes, 2023 for weight) that we have some real-world data on what 3-year and 4-year use looks like. The data is mostly reassuring on safety. It's quiet on the question of whether anyone actually needs to be on it forever.

The honest answer about forever is that we don't know yet. Some patients will probably do well staying on a maintenance dose long-term. Some will be able to come off after a few years and hold weight with lifestyle changes alone. Some will pulse on and off based on life circumstances. Three years from now we'll have better population data than we do now.

What I told the Bangkok patient: the next time your prescriber says "maintenance dose," ask what they specifically mean. Ask what dose. Ask for how long. Ask what the plan is for revisiting whether you can step down. If they don't have a plan, the plan is "stay at this dose indefinitely because we haven't thought about it." That's not a great plan but it's a common one.

The medication is still relatively new. The protocols around long-term use are being figured out empirically by the patients on it and the prescribers paying attention. You're allowed to be part of that conversation. You're supposed to be.

Ask the question. Make them define the term.